2.5. Outcomes
fasting blood glucose, hypoglycemic, postprandial blood glucose
EVENTS, SECONDARY, INSULIN RESISTANCE
The primary end points are liver fat content (ultrasonic quantitative determination of liver fat content), ALT, AST, gamma-GT levels, and insulin resistance index. The secondary endpoints are HbA1c, intravenous fasting blood glucose, 2 h postprandial blood glucose, total cholesterol, triglyceride, HDL cholesterol, LDL cholesterol, waist circumference, and body weight. Safety indicators such as medication compliance, vital signs, hypoglycemic events, nonhypoglycemic events, blood routine, urine routine, and electrocardiogram were analyzed.